These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 29113172)

  • 1. Overexpression of
    Huang Y; Jian W; Zhao J; Wang G
    Onco Targets Ther; 2018; 11():2177-2184. PubMed ID: 29713186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer.
    Jin Y; He J; Du J; Zhang RX; Yao HB; Shao QS
    Oncol Lett; 2017 Nov; 14(5):6191-6197. PubMed ID: 29113266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the TPR-domain immunophilins FKBP51 and FKBP52 in normal physiology and disease.
    Soto OB; Ramirez CS; Koyani R; Rodriguez-Palomares IA; Dirmeyer JR; Grajeda B; Roy S; Cox MB
    J Cell Biochem; 2023 Apr; ():. PubMed ID: 37087733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer.
    Habara M; Sato Y; Goshima T; Sakurai M; Imai H; Shimizu H; Katayama Y; Hanaki S; Masaki T; Morimoto M; Nishikawa S; Toyama T; Shimada M
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2110256119. PubMed ID: 35394865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP52 in Neuronal Signaling and Neurodegenerative Diseases: A Microtubule Story.
    Chambraud B; Byrne C; Meduri G; Baulieu EE; Giustiniani J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
    Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
    Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between
    Zheng K; Yao S; Yao W; Li Q; Wang Y; Zhang L; Chen X; Xiong H; Yuan X; Wang Y; Zou Y; Xiong H
    Front Genet; 2021; 12():770134. PubMed ID: 34790230
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer.
    Hong C; Li T; Zhang F; Wu X; Chen X; Cui X; Zhang G; Cui Y
    Oncol Lett; 2017 Nov; 14(5):5379-5385. PubMed ID: 29113172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
    Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
    BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX12 expression is associated with progression and poor prognosis in human breast cancer.
    Xu J; Zhang J; Li L; Mao J; You T; Li Y
    Am J Transl Res; 2020; 12(12):8162-8174. PubMed ID: 33437389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer survival in China, 2003-2005: a population-based study.
    Zeng H; Zheng R; Guo Y; Zhang S; Zou X; Wang N; Zhang L; Tang J; Chen J; Wei K; Huang S; Wang J; Yu L; Zhao D; Song G; Chen J; Shen Y; Yang X; Gu X; Jin F; Li Q; Li Y; Ge H; Zhu F; Dong J; Guo G; Wu M; Du L; Sun X; He Y; Coleman MP; Baade P; Chen W; Yu XQ
    Int J Cancer; 2015 Apr; 136(8):1921-30. PubMed ID: 25242378
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.